中国P站

Single-cell RNA sequencing; Spatial transcriptomics; Infection; Inflammation; Immune response; COVID-19; Pathogenesis; Therapeutic targets; Biomarkers; Tissue pathology

Introduction

Single-cell spatial transcriptomics offers critical insights into the intricate cellular architecture and immune responses within infected and inflamed tissues. It meticulously details methodologies and applications, underlining its immense potential for pinpointing novel diagnostic biomarkers and therapeutic targets through in situ mapping of cell-type-specific gene expression [1].

One investigation utilized single-cell RNA sequencing (scRNA-seq) to meticulously dissect cell-type-specific transcriptional changes in human lung tissue during influenza A virus infection. This work brought to light distinct host immune responses and pathological alterations at the cellular level, significantly enhancing our understanding of influenza pathogenesis and suggesting new avenues for targeted interventions [2].

Further research, also employing single-cell transcriptomics, unveiled the profound heterogeneity of host immune cells and specific interferon-related gene expression in human tissues severely affected by severe Acute Respiratory Syndrome Coronavirus 2 infection. This particular study was instrumental in delineating the complex immune landscape and the precise cellular responses that contribute to COVID-19 pathology, providing vital insights into disease mechanisms and factors driving severe outcomes [3].

Another application of scRNA-seq explored immune cell dysregulation within human brain tissue during Herpes Simplex Encephalitis. These findings conspicuously highlighted specific immune cell populations and their transcriptional states, which demonstrably contribute to neuroinflammation and tissue damage, thereby offering potential targets for therapeutic modulation in viral encephalitis [4].

Characterizing the immune cell landscape, researchers deployed single-cell RNA sequencing in human adipose tissue during Staphylococcus aureus infection. This analysis brought to light significant alterations in immune cell composition and transcriptional profiles, yielding crucial insights into how adipose tissue responds to bacterial infection and contributes to localized pathology [5].

Mapping host responses, scRNA-seq was employed in lung and gastrointestinal tissues during severe COVID-19 infection. This effort pinpointed specific cell types and pathways that contribute to tissue damage and pathology across different organs, offering a granular view of systemic infection impacts and paving the way for potential therapeutic targets [6].

Defining cell-type-specific signatures of inflammation and metabolism, researchers leveraged scRNA-seq in human liver tissue infected with Schistosoma japonicum. This extensive analysis illuminated distinct cellular responses and metabolic reprogramming within the liver, shedding considerable light on the pathogenesis of schistosomiasis-induced liver pathology [7].

An investigation into human visceral leishmaniasis, utilizing scRNA-seq, specifically pinpointed an IL-13-driven tissue environment. It thoroughly characterized the immune cell profiles and cytokine networks that fundamentally contribute to disease pathology, thereby revealing key orchestrators of the tissue response during this parasitic infection [8].

Focusing on COVID-19-associated pulmonary vascular pathology, single-cell RNA sequencing identified inflammatory macrophages and endothelial cells as central players. The study rigorously elucidated the specific cellular mechanisms contributing to vascular damage and inflammation in the lungs during severe Severe Acute Respiratory Syndrome Coronavirus 2 infection, consequently opening potential therapeutic avenues [9].

Finally, to unravel the cellular and molecular landscape of human lung fibrosis stemming from COVID-19, single-cell transcriptomics was utilized. This provided a high-resolution view of the cell types involved in fibrotic processes and their molecular states, offering crucial insights into post-infectious tissue damage and guiding potential therapeutic strategies for lung recovery [10].

Description

Single-cell spatial transcriptomics, as demonstrated in one study, provides critical insights into the complex cellular architecture and immune responses within infected and inflamed tissues. This methodology is key for identifying novel diagnostic biomarkers and therapeutic targets by mapping cell-type-specific gene expression in situ [1]. More broadly, single-cell RNA sequencing (scRNA-seq) has been a transformative tool for dissecting cell-type-specific transcriptional changes in various human tissues. For instance, it reveals distinct host immune responses and pathological alterations at the cellular level, offering a deeper understanding of various disease pathogeneses and potential avenues for targeted interventions [2]. The power of these single-cell analyses lies in their ability to define cell-type-specific signatures of inflammation and metabolism, illuminating distinct cellular responses and metabolic reprogramming within affected organs [7].

In the context of severe Severe Acute Respiratory Syndrome Coronavirus 2 infection, single-cell transcriptomics has been crucial. Research uncovered the heterogeneity of host immune cells and interferon-related gene expression in human tissues, delineating the complex immune landscape and specific cellular responses contributing to COVID-19 pathology and severe outcomes [3]. Another study mapped host responses in lung and gastrointestinal tissues during severe COVID-19, identifying specific cell types and pathways contributing to tissue damage. This provided a granular view of systemic infection impacts and potential therapeutic targets [6]. Further investigations identified inflammatory macrophages and endothelial cells as central players in COVID-19-associated pulmonary vascular pathology, elucidating specific cellular mechanisms contributing to vascular damage and inflammation in the lungs [9]. Significantly, single-cell transcriptomics also unraveled the cellular and molecular landscape of human lung fibrosis resulting from COVID-19, offering a high-resolution view of cell types involved in fibrotic processes and molecular states, crucial for post-infectious tissue damage and lung recovery strategies [10].

Beyond COVID-19, scRNA-seq has provided insights into other viral infections. It dissected cell-type-specific responses to influenza A virus in human lung tissue, revealing critical changes [2]. Similarly, immune cell dysregulation within human brain tissue during Herpes Simplex Encephalitis was revealed by scRNA-seq. This work highlighted specific immune cell populations and their transcriptional states contributing to neuroinflammation, presenting potential targets for therapeutic modulation in viral encephalitis [4].

The utility of scRNA-seq extends to bacterial and parasitic diseases. Researchers characterized the immune cell landscape in human adipose tissue during Staphylococcus aureus infection, noting significant alterations in immune cell composition and transcriptional profiles that illuminate adipose tissue's response to bacterial infection [5]. For parasitic infections, scRNA-seq defined cell-type-specific signatures of inflammation and metabolism in human liver tissue infected with Schistosoma japonicum [7]. Moreover, it pinpointed an IL-13-driven tissue environment and characterized immune cell profiles and cytokine networks in human visceral leishmaniasis [8].

Collectively, these studies emphasize the profound impact of single-cell technologies in providing a granular understanding of host responses to a wide array of pathogens. They consistently reveal distinct cellular subsets and their unique transcriptional states, which are indispensable for developing targeted interventions, identifying biomarkers, and ultimately improving outcomes across diverse infectious and inflammatory conditions.

Conclusion

Recent advances in single-cell spatial transcriptomics and single-cell RNA sequencing are fundamentally changing our understanding of infection and inflammatory diseases. These powerful technologies provide unprecedented resolution, allowing researchers to dissect complex cellular architectures and immune responses directly within infected and inflamed human tissues. Studies using these methods have revealed critical insights across various pathogens, including viral infections like influenza A, Severe Acute Respiratory Syndrome Coronavirus 2, and Herpes Simplex Encephalitis, as well as bacterial infections such as Staphylococcus aureus, and parasitic diseases like schistosomiasis and visceral leishmaniasis. Key findings consistently highlight cell-type-specific transcriptional changes, immune cell dysregulation, and the heterogeneity of host immune responses. Researchers have identified inflammatory macrophages, endothelial cells, and distinct metabolic reprogramming events that contribute to pathology in diverse organs, including lungs, brain, liver, and adipose tissue. Ultimately, these granular insights are instrumental for identifying novel diagnostic biomarkers, understanding disease mechanisms, and uncovering potential therapeutic targets, paving the way for more precise and effective interventions in infectious and inflammatory conditions.

References

1. Xiaoyu S, Shiqi X, Mingzhou G (2024) .Front Immunol 15:1351119.

   , ,

2. Meng Y, Yunlong L, Junjie D (2023) .J Med Virol 95:e29177.

   , ,

3. Yu-Liang D, Yan W, Rui L (2023) .Int Immunopharmacol 124:109772.

   , ,

4. Yuchan L, Wenbo L, Wen L (2023) .Brain Sci 13:1338.

   , ,

5. Anupama S, Julia EO, Joseph AL (2023) .Cell Microbiol 25:e13627.

   , ,

6. Yuan W, Xiaowei H, Zhaohua Z (2023) .Cell Mol Biol Lett 28:89.

   , ,

7. Jiahui L, Yanyun L, Yingying S (2022) .J Immunol Res 2022:1941656.

   , ,

8. Jennifer EH, Alana PRdM, Sara MdO (2022) .Nat Commun 13:2841.

   , ,

9. Xiaoyan H, Lu H, Qian S (2022) .EBioMedicine 78:103986.

   , ,

10. Xiaoyan H, Lu H, Fang Z (2021) .Cell Res 31:899-915.

    , ,